MetroWest Business Digest for March 27, 2018
Marlborough receives $15K grant
The city of Marlborough has received a $15,000 Massachusetts Downtown Initiative technical assistance program grant, which will be used to develop a branding and wayfinding strategy for the downtown area. Lt. Gov. Karyn Polito announced the grant funding during an award ceremony held at the Marlborough Community Development Authority yesterday. In total, 19 Massachusetts communities received $285,000 in MDI grants during the event. The MDI program makes grant awards of $15,000 to communities to help them pay for technical assistance in the form of workshops, programs and professional consultant services, as part of a holistic approach to downtown revitalization. Since 2015, the Baker-Polito Administration has awarded $725,000 to more than 25 communities across the Commonwealth.
MariMed to exhibit at Hynes Convention Center
MariMed, of Newton, a Massachusetts-based, publicly traded national cannabis company, will exhibit at the New England Cannabis Convention convention, booth 927, at the Hynes Convention Center in Boston on March 24-25. MariMed will be introducing its precision-dosed, licensed branded products to the wide spectrum of attendees interested in the emerging Massachusetts cannabis marketplace. MariMed will also offer a sneak peak of its soon-to-be-introduced Nature’s Heritage Cannabis line of branded product. The company expects to begin distribution of its products to medical cannabis dispensaries in the second quarter of 2018 and the adult use cannabis market after July 2018. MariMed’s branded product lines, which incorporate the purest cannabis strains grown using its eco-friendly sustainable cultivation techniques, include Kalm Fusion, cannabis infused, precision dosed powdered tincture drink mix; Kalm Corn popcorn, oral thin strips and chewable tablets – all in CBD and THC formulations; Betty’s Eddies, precision dosed all-natural fruit chews; Tikun Olam, licensed cannabis strains from Israel, where years of research and clinical trials were conducted with strains to effectively treat specific medical symptoms related